LEADER 01492nam  2200385Ia 450 
001 9910698828903321
005 20090527160105.0
035   $a(CKB)5470000002397579
035   $a(OCoLC)352926672
035   $a(EXLCZ)995470000002397579
100   $a20090527d1999      ua             0
101 0 $aeng
135   $auran|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aGuidance for industry$b[electronic resource] $eprecautionary measures to reduce the possible risk of transmission of zoonoses by blood and blood products from xenotransplantation product recipients and their contacts
210  1$aRockville, MD :$cU.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research,$d[1999]
215   $ai, 9 pages $cdigital, PDF file
300   $aTitle from PDF title page (viewed on May 27, 2009).
300   $a"Draft guidance".
300   $a"December 1999".
300   $aIncludes bibliographical references (p. 7-9).
517   $aGuidance for industry 
606   $aZoonoses$zUnited States$xPrevention
606   $aXenografts$xGovernment policy$zUnited States
615  0$aZoonoses$xPrevention.
615  0$aXenografts$xGovernment policy
712 02$aCenter for Biologics Evaluation and Research (U.S.)
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910698828903321
996   $aGuidance for industry$93434577
997   $aUNINA